ALDH1A1 and breast carcinoma: Also, another study conducted in 203 primary breast cancer patients with ALDH1-positive tumors showed marginally significantly lower RFS (relapse-free survival) rates than those with ALDH1-negative tumors (P=0.056) [30], and this was in agreement with our report.